334 related articles for article (PubMed ID: 9289393)
21. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
[TBL] [Abstract][Full Text] [Related]
22. The role of B-cells in experimental myasthenia gravis in mice.
Wang HB; Li H; He B; Bakheit M; Levi M; Wahren B; Berglöf A; Sandstedt K; Link H; Shi FD
Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244
[TBL] [Abstract][Full Text] [Related]
23. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls.
Link H; Olsson O; Sun J; Wang WZ; Andersson G; Ekre HP; Brenner T; Abramsky O; Olsson T
J Clin Invest; 1991 Jun; 87(6):2191-6. PubMed ID: 1904073
[TBL] [Abstract][Full Text] [Related]
24. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
[TBL] [Abstract][Full Text] [Related]
25. T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls.
Sun JB; Harcourt G; Wang ZY; Hawke S; Olsson T; Fredrikson S; Link H
Eur J Immunol; 1992 Jun; 22(6):1553-9. PubMed ID: 1376263
[TBL] [Abstract][Full Text] [Related]
26. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
Xiao BG; Duan RS; Zhu WH; Lu CZ
Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
Atassi MZ; Oshima M
Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
[TBL] [Abstract][Full Text] [Related]
28. [In vitro immunoglobulin synthesis by peripheral blood mononuclear cells from patients with myasthenia gravis].
Miyazaki Y; Arikawa E; Kubota H; Yagi K; Tanabe H
Rinsho Shinkeigaku; 1990 Jan; 30(1):1-6. PubMed ID: 2331813
[TBL] [Abstract][Full Text] [Related]
29. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
30. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
31. Animal models of myasthenia gravis.
Christadoss P; Poussin M; Deng C
Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and functional characterization of T cells from patients with myasthenia gravis.
Mokhtarian F; Pino M; Ofosu-Appiah W; Grob D
J Clin Invest; 1990 Dec; 86(6):2099-108. PubMed ID: 1979338
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
34. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
Oshima M; Deitiker PR; Smith RG; Mosier D; Atassi MZ
Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
[TBL] [Abstract][Full Text] [Related]
35. Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors.
Christadoss P; Lennon VA; Krco CJ; David CS
J Immunol; 1982 Mar; 128(3):1141-4. PubMed ID: 6799570
[TBL] [Abstract][Full Text] [Related]
36. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
[TBL] [Abstract][Full Text] [Related]
37. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
[TBL] [Abstract][Full Text] [Related]
38. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
Dayan M; Sthoeger Z; Neiman A; Abarbanel J; Sela M; Mozes E
Hum Immunol; 2004 Jun; 65(6):571-7. PubMed ID: 15219376
[TBL] [Abstract][Full Text] [Related]
40. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
Corey AL; Richman DP; Agius MA; Wollmann RL
J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
